HistoCyte – The Role of Accurate Diagnostics

Last updated: 14th June, 2024

HistoCyte tissue controls are a testament to precision and reliability in cancer diagnosis.

Our PD-L1, ER, PR, HER2 controls, and more aim to bring clarity and confidence to patients and healthcare providers. These controls ensure accurate immunohistochemistry (IHC) results, which are pivotal in determining the most effective treatment plans.

Accurate diagnostics serve as the cornerstone of cancer research. Our tools empower researchers to delve deeper into the complexities of cancer, leading to breakthroughs that could revolutionise treatment methods. The HistoCyte tissue controls are crafted to meet the stringent demands of cancer diagnostics and help shape the future of oncology.

  • Precision and Reliability: PD-L1, ER, PR, HER2 controls*, and more ensure accurate diagnostic IHC results, which are essential for effective cancer treatment.

 

  • Supporting Research: Accurate diagnostics are the foundation of successful cancer research. By providing reliable tools, researchers are able to make significant strides in understanding and treating cancer.

Learn more about HistoCyte

View HistoCyte Product Range brochure

Download here >

Learn about Developing Robust PD-L1 Controls for Cancer Companion Diagnostics

Read more >

Learn about HPV/p16 Analyte Control Utility review and ring study results

Read more >

* Research Use Only

THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.



Request a Quote

Request Quote

Go BackGo Back
Top